TRADING UPDATES: Avacta raises funds; Orcadian ends development deal
5th Oct 2026 20:21
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News: Read More
| Price | 63.50p on 07-10-2026 at 18:35:08 |
|---|---|
| Change | -4.50p -6.62% |
| Buy | 64.00p |
| Sell | 63.00p |
| Last Trade: | Buy 75,000.00 at 66.308p |
| Day's Volume: | 2,974,496 |
| Last Close: | 63.50p |
| Open: | 68.50p |
| ISIN: | GB00BYYW9G87 |
| Day's Range | 63.00p - 68.50p |
| 52wk Range: | 49.00p - 90.50p |
| Market Capitalisation: | £290.17m |
| VWAP: | 66.19973p |
| Shares in Issue: | 456.96m |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
Avacta Group (AVCT) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 75,000 | 66.308p | Ordinary |
16:41:19 - 07-Oct-26 |
| Buy* | 7,000 | 64.00p | Ordinary |
16:29:50 - 07-Oct-26 |
| Buy* | 17,500 | 64.00p | Ordinary |
16:29:42 - 07-Oct-26 |
| Buy* | 30,000 | 64.00p | Ordinary |
16:29:14 - 07-Oct-26 |
| Buy* | 10,000 | 64.00p | Ordinary |
16:29:11 - 07-Oct-26 |
| Buy* | 107 | 64.00p | Ordinary |
16:29:03 - 07-Oct-26 |
| Buy* | 15,484 | 64.00p | Ordinary |
16:28:44 - 07-Oct-26 |
| Buy* | 31,631 | 63.25p | Ordinary |
16:28:42 - 07-Oct-26 |
| Buy* | 20,000 | 63.97p | Ordinary |
16:28:22 - 07-Oct-26 |
| Buy* | 797 | 63.25p | Ordinary |
16:28:12 - 07-Oct-26 |
Avacta Group (AVCT) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 6th Oct 2026 7:30 am | RNS | Capital Access Window - Avacta Group Plc |
| 6th Oct 2026 7:00 am | RNS | Results of Placing and Subscription |
| 5th Oct 2026 4:22 pm | RNS | Proposed Fundraise to raise approximately £12.5m |
| 30th Sep 2026 7:30 am | RNS | Capital Access Window - Avacta Group Plc |
| 30th Sep 2026 7:01 am | RNS | Capital Access Window |
| 30th Sep 2026 7:00 am | RNS | Interim Results for Six Months to June 30, 2026 |
| 25th Sep 2026 8:00 am | RNS-R | pre|CISION® Platform Wins R&D Achievement Award |
| 25th Sep 2026 7:00 am | RNS | Further Demonstration of Potential of AVA6103 |
| 16th Sep 2026 7:00 am | RNS | Clinical Proof of Mechanism for preCISION Platform |
| 14th Sep 2026 7:00 am | RNS | Mats Blom to Board as Chair of Audit Committee |